Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

Cardiac implantable electronic devices can be safely reprogrammed to MRI-safe mode via remote operator

In 209 study participants, the remote reprogramming resulted in a successful, event-free MRI scan for every patient.

Siemens Healthineers showed examples at ACC 2022 of cardiac computed tomography (CT) from its new Naeotom Alpha photon-counting CT scanner cleared by the FDA in 2021.

VIDEO: Example of photo-counting cardiac CT with calcified coronaries

Siemens Healthineers showed examples at ACC 2022 of cardiac computed tomography (CT) from its new Naeotom Alpha photon-counting CT scanner cleared by the FDA in 2021.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance. 

The GE healthcare vScan Air was one of several point of care ultrasound (POCUS) systems on display at the ACC 2022 meeting.

VIDEO: Point-of-care ultrasound systems at ACC 2022

There were several point-of-care ultrasound (POCUS) systems on display by vendors at ACC 2022. Here are two of them. 

Thumbnail

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes. 

interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead. 

Brugada arrhythmogenic substrate that causes VT and sudden cardiac death. This study showed ablation of this substrate area could help prevent sudden cardiac arrest in these patients.

Epicardial ablation in Brugada syndrome reduces sudden cardiac death

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

New-look protocol boosts outcomes among AFib patients in the ER

A large proportion of patients with atrial fibrillation (AFib) end up in emergency rooms (ERs), but there are inherent issues with most hospital ERs handing off these patients to electrophysiologists for follow-up care.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.